{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T17:38:03Z","timestamp":1769017083037,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":645,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1038\/mtna.2015.25","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T15:22:18Z","timestamp":1441120938000},"page":"e251","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Modular Assembly of Cell-targeting Devices Based on an Uncommon G-quadruplex Aptamer"],"prefix":"10.1016","volume":"4","author":[{"given":"Felipe","family":"Opazo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Eiden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falk","family":"Rohrbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Wengel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen","family":"Kjems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mtna.2015.25_bib1","doi-asserted-by":"crossref","first-page":"8149","DOI":"10.1002\/anie.200602251","article-title":"An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform","volume":"45","author":"Bagalkot","year":"2006","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1038\/mtna.2015.25_bib2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/mt.2014.5","article-title":"Multifunctional aptamer-miRNA conjugates for targeted cancer therapy","volume":"22","author":"Esposito","year":"2014","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2015.25_bib3","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1093\/nar\/gkl388","article-title":"Aptamer mediated siRNA delivery","volume":"34","author":"Chu","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2015.25_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/nat.2013.0472","article-title":"Multifunctional nucleic acids for tumor cell treatment","volume":"24","author":"Pofahl","year":"2014","journal-title":"Nucleic Acid Ther"},{"key":"10.1038\/mtna.2015.25_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2015.05.276","article-title":"Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates","volume":"210","author":"Catuogno","year":"2015","journal-title":"J Control Release"},{"key":"10.1038\/mtna.2015.25_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.molmed.2015.01.001","article-title":"Cancer nanomedicine: from targeted delivery to combination therapy","volume":"21","author":"Xu","year":"2015","journal-title":"Trends Mol Med"},{"key":"10.1038\/mtna.2015.25_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/cmdc.201402312","article-title":"Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy","volume":"10","author":"Zhu","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1038\/mtna.2015.25_bib8","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1038\/mtna.2014.21","article-title":"Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy","volume":"3","author":"Zhou","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1038\/mtna.2015.25_bib9","doi-asserted-by":"crossref","first-page":"e87002","DOI":"10.1371\/journal.pone.0087002","article-title":"From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors","volume":"9","author":"Cibiel","year":"2014","journal-title":"PLoS One"},{"key":"10.1038\/mtna.2015.25_bib10","first-page":"4029","article-title":"Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen","volume":"62","author":"Lupold","year":"2002","journal-title":"Cancer Res"},{"key":"10.1038\/mtna.2015.25_bib11","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1073\/pnas.0601755103","article-title":"Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo","volume":"103","author":"Farokhzad","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2015.25_bib12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt1223","article-title":"Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras","volume":"24","author":"McNamara","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mtna.2015.25_bib13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4161\/rna.6.3.8808","article-title":"Aptamers and aptamer targeted delivery","volume":"6","author":"Yan","year":"2009","journal-title":"RNA Biol"},{"key":"10.1038\/mtna.2015.25_bib14","doi-asserted-by":"crossref","first-page":"10541","DOI":"10.1002\/anie.201405778","article-title":"An aptamer intrinsically comprising 5-fluoro-2\u2019-deoxyuridine for targeted chemotherapy","volume":"53","author":"Kruspe","year":"2014","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1038\/mtna.2015.25_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-4939-2432-5_11","article-title":"Aptamer-siRNA chimeras for HIV","volume":"848","author":"Takahashi","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1038\/mtna.2015.25_bib16","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/mt.2014.51","article-title":"Aptamer-targeted antigen delivery","volume":"22","author":"Wengerter","year":"2014","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2015.25_bib17","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.1560","article-title":"Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors","volume":"27","author":"Dassie","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mtna.2015.25_bib18","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1021\/nn301869z","article-title":"Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities","volume":"6","author":"Xiao","year":"2012","journal-title":"ACS Nano"},{"key":"10.1038\/mtna.2015.25_bib19","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/nprot.2010.163","article-title":"Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures","volume":"5","author":"Mayer","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1038\/mtna.2015.25_bib20","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1002\/anie.200800216","article-title":"Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting","volume":"47","author":"Raddatz","year":"2008","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1038\/mtna.2015.25_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4161\/rna.22951","article-title":"d(GGGT) 4 and r(GGGU) 4 are both HIV-1 inhibitors and interleukin-6 receptor aptamers","volume":"10","author":"Magbanua","year":"2013","journal-title":"RNA Biol"},{"key":"10.1038\/mtna.2015.25_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4161\/rna.9.1.18062","article-title":"Interleukin-6 receptor specific RNA aptamers for cargo delivery into target cells","volume":"9","author":"Meyer","year":"2012","journal-title":"RNA Biol"},{"key":"10.1038\/mtna.2015.25_bib23","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/cbic.200500198","article-title":"Light-induced formation of G-quadruplex DNA secondary structures","volume":"6","author":"Mayer","year":"2005","journal-title":"Chembiochem"},{"key":"10.1038\/mtna.2015.25_bib24","doi-asserted-by":"crossref","first-page":"8984","DOI":"10.1093\/nar\/gkr540","article-title":"HIV-1 integrase inhibitor T30177 forms a stacked dimeric G-quadruplex structure containing bulges","volume":"39","author":"Mukundan","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2015.25_bib25","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1021\/ja310251r","article-title":"Bulges in G-quadruplexes: broadening the definition of G-quadruplex-forming sequences","volume":"135","author":"Mukundan","year":"2013","journal-title":"J Am Chem Soc"},{"key":"10.1038\/mtna.2015.25_bib26","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1039\/c1cs15048k","article-title":"Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals","volume":"40","author":"Campbell","year":"2011","journal-title":"Chem Soc Rev"},{"key":"10.1038\/mtna.2015.25_bib27","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1073\/pnas.97.10.5633","article-title":"Potent and nontoxic antisense oligonucleotides containing locked nucleic acids","volume":"97","author":"Wahlestedt","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2015.25_bib28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3390\/ijms9030422","article-title":"Effect of locked-nucleic acid on a biologically active g-quadruplex. A structure-activity relationship of the thrombin aptamer","volume":"9","author":"Bonifacio","year":"2008","journal-title":"Int J Mol Sci"},{"key":"10.1038\/mtna.2015.25_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cbic.201200015","article-title":"Chemical maturation of a bivalent aptamer by single domain variation","volume":"13","author":"Rohrbach","year":"2012","journal-title":"Chembiochem"},{"key":"10.1038\/mtna.2015.25_bib30","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.bmc.2010.01.054","article-title":"Conservative secondary structure motif of streptavidin-binding aptamers generated by different laboratories","volume":"18","author":"Bing","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1038\/mtna.2015.25_bib31","doi-asserted-by":"crossref","first-page":"11486","DOI":"10.1021\/ja803086r","article-title":"Second-generation difluorinated cyclooctynes for copper-free click chemistry","volume":"130","author":"Codelli","year":"2008","journal-title":"J Am Chem Soc"},{"key":"10.1038\/mtna.2015.25_bib32","doi-asserted-by":"crossref","first-page":"E471","DOI":"10.1073\/pnas.1115495109","article-title":"Rabenosyn-5 defines the fate of the transferrin receptor following clathrin-mediated endocytosis","volume":"109","author":"Navaroli","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2015.25_bib33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.18433\/J3N590","article-title":"Targeting the C-type lectins-mediated host-pathogen interactions with dextran","volume":"17","author":"Pustylnikov","year":"2014","journal-title":"J Pharm Pharm Sci"},{"key":"10.1038\/mtna.2015.25_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0076-6879(07)38006-3","article-title":"Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis","volume":"438","author":"Kirchhausen","year":"2008","journal-title":"Methods Enzymol"},{"key":"10.1038\/mtna.2015.25_bib35","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1038\/mtna.2012.14","article-title":"An RNA alternative to human transferrin: a new tool for targeting human cells","volume":"1","author":"Wilner","year":"2012","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1038\/mtna.2015.25_bib36","doi-asserted-by":"crossref","first-page":"8617","DOI":"10.1158\/0008-5472.CAN-10-0920","article-title":"A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism","volume":"70","author":"Reyes-Reyes","year":"2010","journal-title":"Cancer Res"},{"key":"10.1038\/mtna.2015.25_bib37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","article-title":"Endosomal escape pathways for delivery of biologicals","volume":"151","author":"Varkouhi","year":"2011","journal-title":"J Control Release"},{"key":"10.1038\/mtna.2015.25_bib38","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1021\/ar3000162","article-title":"Nucleic acid delivery: the missing pieces of the puzzle?","volume":"45","author":"Nguyen","year":"2012","journal-title":"Acc Chem Res"},{"key":"10.1038\/mtna.2015.25_bib39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.chembiol.2008.05.016","article-title":"Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer","volume":"15","author":"Dollins","year":"2008","journal-title":"Chem Biol"},{"key":"10.1038\/mtna.2015.25_bib40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1172\/JCI33365","article-title":"Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice","volume":"118","author":"McNamara","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mtna.2015.25_bib41","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/mabi.200900046","article-title":"A hybrid DNA aptamer-dendrimer nanomaterial for targeted cell labeling","volume":"9","author":"Zhou","year":"2009","journal-title":"Macromol Biosci"},{"key":"10.1038\/mtna.2015.25_bib42","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1093\/nar\/gkh862","article-title":"Application of locked nucleic acids to improve aptamer in vivo stability and targeting function","volume":"32","author":"Schmidt","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2015.25_bib43","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1074\/mcp.M700026-MCP200","article-title":"Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells","volume":"6","author":"Mallikaratchy","year":"2007","journal-title":"Mol Cell Proteomics"},{"key":"10.1038\/mtna.2015.25_bib44","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1002\/anie.201204174","article-title":"Aptamer-based affinity labeling of proteins","volume":"51","author":"Vinkenborg","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1038\/mtna.2015.25_bib45","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.chembiol.2009.03.007","article-title":"An exosite-specific ssDNA aptamer inhibits the anticoagulant functions of activated protein C and enhances inhibition by protein C inhibitor","volume":"16","author":"M\u00fcller","year":"2009","journal-title":"Chem Biol"},{"key":"10.1038\/mtna.2015.25_bib46","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1261\/rna.821908","article-title":"An RNA molecule that specifically inhibits G-protein-coupled receptor kinase 2 in vitro","volume":"14","author":"Mayer","year":"2008","journal-title":"RNA"},{"key":"10.1038\/mtna.2015.25_bib47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-59745-557-2_2","article-title":"In vitro selection of ssDNA aptamers using biotinylated target proteins","volume":"535","author":"Mayer","year":"2009","journal-title":"Methods Mol Biol"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253116300361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253116300361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T20:30:26Z","timestamp":1537389026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253116300361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":47,"alternative-id":["S2162253116300361"],"URL":"https:\/\/doi.org\/10.1038\/mtna.2015.25","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]},"article-number":"e251"}}